CELG.RT

Bristol-Myers Squibb Company Contingent Value Rights

18 hedge funds and large institutions have $169K invested in Bristol-Myers Squibb Company Contingent Value Rights in 2022 Q3 according to their latest regulatory filings, with funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 1 closing their positions.

Holders
18
Holders Change
-1
Holders Change %
-5.26%
% of All Funds
0.31%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
Increased
3
Reduced
1
Closed
1
Calls
Puts
Net Calls
Net Calls Change